When Luzmila Salazar learned she had cervical cancer, she felt like her life was crumbling around her. “It was the worst thing I’d ever heard,” said the 43-year-old mother of...

John S. Howell likes to talk about his good fortune. “I feel like the luckiest guy in the world,” he’ll say, right at the start of a conversation. Five minutes...

When postal worker Juan Yee was told that his non-Hodgkin’s lymphoma had relapsed for a second time in 2018, he was ready to let nature take its course.  “I couldn’t...

CONTACT Letisia Marquez 626-476-7593 lemarquez@coh.org Mosunetuzumab treats people with relapsed or refractory follicular lymphoma, the most common slow-growing form of non-Hodgkin’s lymphoma LOS ANGELES — A trial led by City...

Usually we write about successful trials that introduce new, advanced treatments. This article, though, is about a trial that failed — but a failure that was so significant, it was...

CONTACT Zen Logsdon 626-409-9367zlogsdon@coh.org The new data is a foundational step to debunking the perception that immunotherapy is not effective in treating advanced colorectal cancer patients with a biomarker...

Overcoming CAR T cell therapy limitations to treat solid tumor cancers By genetically engineering a tumor-selective oncolytic virus to deliver the surface antigen CD19 for expression on solid tumor cells...